Hamartoma with digital breast tomosynthesis

Dec 2, 2007

DBT has demonstrated the ability to reduce false-positive results.

none
Latest in Breast
Breast Imaging Computer Screen Thumbnail (1)
Lobular breast histology not strong predictor of SLNB positivity
January 7, 2026
Contrast Injector 400 (1)
CEM is a reliable tool for evaluating screening recalls
January 5, 2026
Breast Screening Mammo 400
Most women positive toward receiving breast cancer risk communication
January 2, 2026
Ultrasound Diagnostic 400
Age affects abnormal interpretation rates for combined DBT, WBUS
December 30, 2025
Related Stories
2007 11 16 08 47 06 706
Breast
CAD vs. radiologist second reads: What's better for screening mammograms?
2007 10 25 13 25 30 706
Ultrasound
Advanced Imaging Technologies
2007 10 29 09 12 04 706
MRI
Breast MR centers must look beyond imaging and offer universal care
2007 10 30 15 56 57 706
Breast
Siemens Medical Solutions
More in Breast
Lobular breast histology not strong predictor of SLNB positivity
By Amerigo Allegretto
Lobular histology is not a strong predictor of sentinel lymph node biopsy (SLNB) positivity in early-stage breast cancer cases.
January 7, 2026
Breast Imaging Computer Screen Thumbnail (1)
CEM is a reliable tool for evaluating screening recalls
By Amerigo Allegretto
Research shows that contrast-enhanced mammography (CEM) can accurately evaluate recalled screening mammograms.
January 5, 2026
Contrast Injector 400 (1)
Most women positive toward receiving breast cancer risk communication
By Amerigo Allegretto
Most women perceive easing worry as an advantage of learning their breast cancer risk and screening plan.
January 2, 2026
Breast Screening Mammo 400
Age affects abnormal interpretation rates for combined DBT, WBUS
By Amerigo Allegretto
Abnormal interpretation rates vary with age when combining digital breast tomosynthesis (DBT) with whole-breast ultrasound (WBUS).
December 30, 2025
Ultrasound Diagnostic 400
Brain imaging, billing, radiation exposure top 2025's most-read list
By Liz Carey
Snapshots we've curated in this roundup make it easy for you to review what AuntMinnie's members read the most in 2025.
December 22, 2025
Top 10 Paint
75% gadolinium reduction maintains diagnostic sensitivity in breast MRI
By Liz Carey
Study suggests real-world feasibility of AI-driven dose reduction with preserved diagnostic confidence in breast imaging.
December 22, 2025
Gadolinium Social
Lumicell to work with Learn Look Locate for lumpectomy education
By AuntMinnie.com staff writers
Lumicell is working with Learn Look Locate to launch a new educational resource for lumpectomy surgery.
December 18, 2025
Breast Cancer3 400
New breast ultrasound approach cuts false positives by nearly a third
By Amerigo Allegretto
Applying a generalized contrast-to-noise ratio to short-lag spatial coherence breast images could help reduce false positives.
December 17, 2025
2025 12 02 Media Release Graphic New Tech In Breast Ultrasounds Thumbnail
Hologic highlights results from a study on AI-powered mammography
By AuntMinnie.com staff writers
Hologic's Genius AI Detection flagged 32% of false-negative cases and nearly 90% of identified cancers.
December 16, 2025
Hologic Rsna 2019 400
Study highlights risk-based breast cancer screening; ACR responds
By Amerigo Allegretto
A study showing the potential benefits of risk-based breast cancer screening has drawn criticism from the ACR.
December 12, 2025
Doctor Patient Consult Tablet
Radiologists can designate nonmass lesions on breast ultrasound
By Amerigo Allegretto
Breast radiologists achieved moderate to substantial interreader agreement for classifying nonmass lesions on ultrasound.
December 9, 2025
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
ACR talks BI-RADS version 2025 with AuntMinnie
By Amerigo Allegretto
ACR members discussed the need to release the latest version of BI-RADS and what changes breast radiologists can expect.
December 8, 2025
Acr Logo 2023 400
Page 1 of 577
Next Page